Clinical Trials Directory

Trials / Unknown

UnknownNCT02923622

Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer

Status
Unknown
Phase
Study type
Observational
Enrollment
384 (estimated)
Sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Although patients of colorectal cancer use Traditional Chinese Medicine (TCM) herbal therapy extensively in China, no strong evidence exists to demonstrate the safety and survival outcomes of TCM herbal therapy combined with conventional western medicine for treatment of this disease. The purpose of this multi-center perspective cohort study is to evaluate the relationship between TCM herbal therapy and survival outcomes in patients with advanced colorectal cancer.

Conditions

Interventions

TypeNameDescription
OTHERTraditional Chinese medicine herbalsTCM herbal treatment based on TCM syndrome differentiation,without any anti tumor therapy in Western Medicine
OTHERIntegrated traditional Chinese and Western medicineTCM herbal treatment combine with anti tumor therapy in Western Medicine ( including non recommended chemotherapy, radiotherapy and targeted therapy in clinical guidelines)
OTHERWestern medicineAnti tumor therapy in Western Medicine ( including non recommended chemotherapy, radiotherapy and targeted therapy in clinical guidelines)

Timeline

Start date
2016-09-01
Primary completion
2020-03-01
First posted
2016-10-04
Last updated
2016-10-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02923622. Inclusion in this directory is not an endorsement.